11025 related articles for article (PubMed ID: 12876552)
1. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
[TBL] [Abstract][Full Text] [Related]
2. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
3. Validation of the 7-Minute Screen for the detection of early-stage Alzheimer's disease.
Ijuin M; Homma A; Mimura M; Kitamura S; Kawai Y; Imai Y; Gondo Y
Dement Geriatr Cogn Disord; 2008; 25(3):248-55. PubMed ID: 18270487
[TBL] [Abstract][Full Text] [Related]
4. Differentiation between mild cognitive impairment, Alzheimer's disease and depression by means of cued recall.
Dierckx E; Engelborghs S; De Raedt R; De Deyn PP; Ponjaert-Kristoffersen I
Psychol Med; 2007 May; 37(5):747-55. PubMed ID: 17164030
[TBL] [Abstract][Full Text] [Related]
5. The Clock Drawing Test for dementia of the Alzheimer's type: A comparison of three scoring methods in a memory disorders clinic.
Brodaty H; Moore CM
Int J Geriatr Psychiatry; 1997 Jun; 12(6):619-27. PubMed ID: 9215942
[TBL] [Abstract][Full Text] [Related]
6. Does the combination of the MMSE and clock drawing test (mini-clock) improve the detection of mild Alzheimer's disease and mild cognitive impairment?
Cacho J; Benito-León J; García-García R; Fernández-Calvo B; Vicente-Villardón JL; Mitchell AJ
J Alzheimers Dis; 2010; 22(3):889-96. PubMed ID: 20858951
[TBL] [Abstract][Full Text] [Related]
7. [Mild cognitive impairment and Alzheimer's disease: an investigation of the CERAD-NP test battery].
Barth S; Schönknecht P; Pantel J; Schröder J
Fortschr Neurol Psychiatr; 2005 Oct; 73(10):568-76. PubMed ID: 16217697
[TBL] [Abstract][Full Text] [Related]
8. CAMcog as a screening tool for diagnosis of mild cognitive impairment and dementia in a Brazilian clinical sample of moderate to high education.
Nunes PV; Diniz BS; Radanovic M; Abreu ID; Borelli DT; Yassuda MS; Forlenza OV
Int J Geriatr Psychiatry; 2008 Nov; 23(11):1127-33. PubMed ID: 18464287
[TBL] [Abstract][Full Text] [Related]
9. Recognition of Alzheimer's disease: the 7 Minute Screen.
Solomon PR; Pendlebury WW
Fam Med; 1998 Apr; 30(4):265-71. PubMed ID: 9568495
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of Post-traumatic Stress Disorder: validation of a measure, the PCLS].
Yao SN; Cottraux J; Note I; De Mey-Guillard C; Mollard E; Ventureyra V
Encephale; 2003; 29(3 Pt 1):232-8. PubMed ID: 12876547
[TBL] [Abstract][Full Text] [Related]
11. [Personality disorders in a nonclinical sample of adolescents].
Chabrol H; Chouicha K; Montovany A; Callahan S; Duconge E; Sztulman H
Encephale; 2002; 28(6 Pt 1):520-4. PubMed ID: 12506264
[TBL] [Abstract][Full Text] [Related]
12. [Dementia following bipolar disorder].
Lebert F; Lys H; Haëm E; Pasquier F
Encephale; 2008 Dec; 34(6):606-10. PubMed ID: 19081458
[TBL] [Abstract][Full Text] [Related]
13. Screening for Alzheimer's disease with the short cognitive evaluation battery.
Robert PH; Schuck S; Dubois B; Olié JP; Lépine JP; Gallarda T; Goni S; Troy S;
Dement Geriatr Cogn Disord; 2003; 15(2):92-8. PubMed ID: 12566598
[TBL] [Abstract][Full Text] [Related]
14. [Discriminatory validity and association of the mini-mental test (MMSE) and the memory alteration test (M@T) with a neuropsychological battery in patients with amnestic mild cognitive impairment and Alzheimer's disease].
Rami L; Bosch B; Valls-Pedret C; Caprile C; Sánchez-Valle Díaz R; Molinuevo JL
Rev Neurol; 2009 Aug 16-31; 49(4):169-74. PubMed ID: 19621317
[TBL] [Abstract][Full Text] [Related]
15. Screening of mild cognitive impairment in Chinese older adults--a multistage validation of the Chinese abbreviated mild cognitive impairment test.
Lam LC; Tam CW; Lui VW; Chan WC; Chan SS; Chiu HF; Leung T; Tham MK; Ho KS; Chan WM
Neuroepidemiology; 2008; 30(1):6-12. PubMed ID: 18204291
[TBL] [Abstract][Full Text] [Related]
16. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].
Mouchabac S; Ferreri M; Cabanac F; Bitton M
Encephale; 2003; 29(5):438-44. PubMed ID: 14615693
[TBL] [Abstract][Full Text] [Related]
17. CERAD test performances in amnestic mild cognitive impairment and Alzheimer's disease.
Karrasch M; Sinervä E; Grönholm P; Rinne J; Laine M
Acta Neurol Scand; 2005 Mar; 111(3):172-9. PubMed ID: 15691286
[TBL] [Abstract][Full Text] [Related]
18. A study of the Alzheimer's Disease Assessment Scale-Cognitive (ADAS-Cog) in an Icelandic elderly population.
Hannesdóttir K; Snaedal J
Nord J Psychiatry; 2002; 56(3):201-6. PubMed ID: 12079572
[TBL] [Abstract][Full Text] [Related]
19. [Depression and frontal dysfunction: risks for the elderly?].
Thomas P; Hazif Thomas C; Billon R; Peix R; Faugeron P; Clément JP
Encephale; 2009 Sep; 35(4):361-9. PubMed ID: 19748373
[TBL] [Abstract][Full Text] [Related]
20. Impaired insight in Alzheimer disease: association with cognitive deficits, psychiatric symptoms, and behavioral disturbances.
Harwood DG; Sultzer DL; Wheatley MV
Neuropsychiatry Neuropsychol Behav Neurol; 2000 Apr; 13(2):83-8. PubMed ID: 10780626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
